25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2 - PubMed (original) (raw)
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2
Antonio D'Avolio et al. Nutrients. 2020.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), with a clinical outcome ranging from mild to severe, including death. To date, it is unclear why some patients develop severe symptoms. Many authors have suggested the involvement of vitamin D in reducing the risk of infections; thus, we retrospectively investigated the 25-hydroxyvitamin D (25(OH)D) concentrations in plasma obtained from a cohort of patients from Switzerland. In this cohort, significantly lower 25(OH)D levels (p = 0.004) were found in PCR-positive for SARS-CoV-2 (median value 11.1 ng/mL) patients compared with negative patients (24.6 ng/mL); this was also confirmed by stratifying patients according to age >70 years. On the basis of this preliminary observation, vitamin D supplementation might be a useful measure to reduce the risk of infection. Randomized controlled trials and large population studies should be conducted to evaluate these recommendations and to confirm our preliminary observation.
Keywords: COVID-19; SARS-CoV-2; concentrations; coronavirus; deficiency; vitamin D.
Conflict of interest statement
The authors declare that they have no conflict of interest and no competing financial interests.
Figures
Figure 1
25-hydroxyvitamin D concentrations in the three evaluated groups (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR for SARS-CoV-2. *: significant results.
Figure 2
(A) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by gender (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR to SARS-CoV-2; (B) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by age (0–70 years vs. >70 years) (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR for SARS-CoV-2. *: significant results.
Figure 2
(A) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by gender (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR to SARS-CoV-2; (B) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by age (0–70 years vs. >70 years) (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR for SARS-CoV-2. *: significant results.
Similar articles
- SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.
Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. Kaufman HW, et al. PLoS One. 2020 Sep 17;15(9):e0239252. doi: 10.1371/journal.pone.0239252. eCollection 2020. PLoS One. 2020. PMID: 32941512 Free PMC article. - Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Grant WB, et al. Nutrients. 2020 Apr 2;12(4):988. doi: 10.3390/nu12040988. Nutrients. 2020. PMID: 32252338 Free PMC article. Review. - Perspective: improving vitamin D status in the management of COVID-19.
Ebadi M, Montano-Loza AJ. Ebadi M, et al. Eur J Clin Nutr. 2020 Jun;74(6):856-859. doi: 10.1038/s41430-020-0661-0. Epub 2020 May 12. Eur J Clin Nutr. 2020. PMID: 32398871 Free PMC article. Review. No abstract available. - Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry.
Pizzini A, Aichner M, Sahanic S, Böhm A, Egger A, Hoermann G, Kurz K, Widmann G, Bellmann-Weiler R, Weiss G, Tancevski I, Sonnweber T, Löffler-Ragg J. Pizzini A, et al. Nutrients. 2020 Sep 11;12(9):2775. doi: 10.3390/nu12092775. Nutrients. 2020. PMID: 32932831 Free PMC article. - Point of view: Should COVID-19 patients be supplemented with vitamin D?
Annweiler C, Cao Z, Sabatier JM. Annweiler C, et al. Maturitas. 2020 Oct;140:24-26. doi: 10.1016/j.maturitas.2020.06.003. Epub 2020 Jun 8. Maturitas. 2020. PMID: 32972631 Free PMC article. Review.
Cited by
- Serum 25-hydroxyvitamin D levels and health outcomes of hospitalization owing to COVID-19: a retrospective cross-sectional study.
Metonidze I, Bostoganashvili N, Goderidze T, Tananashvili D. Metonidze I, et al. J Int Med Res. 2024 Aug;52(8):3000605241271770. doi: 10.1177/03000605241271770. J Int Med Res. 2024. PMID: 39188127 Free PMC article. - Dietary patterns and micronutrients in respiratory infections including COVID-19: a narrative review.
Salehi Z, Askari M, Jafari A, Ghosn B, Surkan PJ, Hosseinzadeh-Attar MJ, Pouraram H, Azadbakht L. Salehi Z, et al. BMC Public Health. 2024 Jun 21;24(1):1661. doi: 10.1186/s12889-024-18760-y. BMC Public Health. 2024. PMID: 38907196 Free PMC article. Review. - Traditional Chinese medicine for the COVID-19 pandemic: An online cross-sectional survey among health care workers.
Jin X, Xu L, Lu C, Xue X, Liu X, Zhou Y, Hu X, Liu J, Pei X. Jin X, et al. Eur J Integr Med. 2023 Jun 27:102273. doi: 10.1016/j.eujim.2023.102273. Online ahead of print. Eur J Integr Med. 2023. PMID: 38620124 Free PMC article. - Comparative Performance Assessment of Novel Fluorescence Immunoassay POCTs for Measuring Circulating Levels of Vitamin-D.
Palermiti A, Manca A, Mastrantonio F, Maiese D, Curatolo A, Antonucci M, Simiele M, De Nicolò A, D'Avolio A. Palermiti A, et al. Molecules. 2024 Apr 5;29(7):1636. doi: 10.3390/molecules29071636. Molecules. 2024. PMID: 38611915 Free PMC article. - An overview of regulation for nutraceuticals and concept of personalized nutraceuticals.
Tomar S, Musyuni P, Aggarwal G. Tomar S, et al. J Generic Med. 2023 Jun;19(2):66-74. doi: 10.1177/17411343221150875. Epub 2023 Jan 13. J Generic Med. 2023. PMID: 38603246 Free PMC article. Review.
References
- McCartney D.M., Byrne D.G. Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19. Ir. Med. J. 2020;113:58. - PubMed
- Molloy E.J., Murphy N. Vitamin D, Covid-19 and Children. Ir. Med. J. 2020;113:64. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous